KLI

검색

Ulsan Univ. Repository

Browsing by 저자 : Kyung Hae Jung

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

가 나 다 라 마 바 사 아 자 차 카 타 파 하

또는 첫 단어:

정렬 기준:
정렬:
결과 수
저자 수

전체 결과 12건 중 1-12 번을 표시중입니다.

1 Article Association between tumor 18 F-fluorodeoxyglucose metabolism and survival in women with estrogen receptor-positive, HER2-negative breast cancer Sun Young Chae ; Seol Hoon Park ; Hyo Sang Lee ; et al 2022
2 Article Comparison of the Effectiveness and Clinical Outcome of Everolimus Followed by CDK4/6 Inhibitors with the Opposite Treatment Sequence in Hormone Receptor?Positive, HER2-Negative Metastatic Breast Cancer Hyehyun Jeong ; Jae Ho Jeong ; Jeong Eun Kim ; et al 2022
3 Article CT Findings From Interstitial Lung Diseases in Patients With Metastatic Breast Cancer Treated With Fam-Trastuzumab Deruxtecan: A Single Institutional Experience Yoon Jung Jang ; Jae Ho Jeong ; Jeong Eun Kim ; et al 2022
4 Article Exploratory analysis of biomarkers associated with clinical outcomes from the study of palbociclib plus endocrine therapy in premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer Soohyeon Lee ; Kyunghee Park ; Gun Min Kim ; et al 2022
5 Article Integrin αvβ3 Induces HSP90 Inhibitor Resistance via FAK Activation in KRAS-Mutant Non-Small Cell Lung Cancer Shinkyo Yoon ; Hannah Yang ; Hyun-Min Ryu ; et al 2022
6 Article Noncirrhotic Portal Hypertension after Trastuzumab Emtansine in HER2-positive Breast Cancer as Determined by Deep Learning-measured Spleen Volume at CT Se Jin Choi ; Seung Soo Lee ; Kyung Hae Jung ; et al 2022
7 Article Phase II study to investigate the efficacy of trastuzumab biosimilar (Herzuma®) plus treatment of physician's choice (TPC) in patients with heavily pretreated HER-2+ metastatic breast cancer (KCSG BR 18-14/KM10B) Sung Hoon Sim ; Jeong Eun Kim ; Min Hwan Kim ; et al 2022
8 Article Prevalence of mutations in BRCA and homologous recombination repair genes and real-world standard of care of Asian patients with HER2-negative metastatic breast cancer starting first-line systemic cytotoxic chemotherapy: subgroup analysis of the global BREAKOUT study Su-Jin Koh ; Shozo Ohsumi ; Masato Takahashi ; et al 2022
9 Article Response Rate and Safety of a Neoadjuvant Pertuzumab, Atezolizumab, Docetaxel, and Trastuzumab Regimen for Patients With ERBB2-Positive Stage II/III Breast Cancer Hee Kyung Ahn ; Sung Hoon Sim ; Koung Jin Suh ; et al 2022
10 Article Safety and efficacy of adjuvant subcutaneous trastuzumab in human epidermal growth factor receptor 2-positive early breast cancer: Final results of the SafeHER study Joseph Gligorov ; Xavier Pivot ; Beyhan Ataseven ; et al 2022
11 Article The impact of systematic assessment for adverse events on unscheduled hospital utilization in patients receiving neoadjuvant or adjuvant chemotherapy: A retrospective multicenter study Jwa Hoon Kim ; Seyoung Seo ; Jee Hyun Kim ; et al 2022
12 Article Updated Overall Survival of Ribociclib plus Endocrine Therapy versus Endocrine Therapy Alone in Pre- and Perimenopausal Patients with HR+/HER2- Advanced Breast Cancer in MONALEESA-7: A Phase III Randomized Clinical Trial Yen-Shen Lu ; Seock-Ah Im ; Marco Colleoni ; et al 2022

OAK Ulsan Univ. Repository는 국립중앙도서관 OAK Repository 보급사업으로 구축되었습니다.